Report Description

Global Tendonitis Treatment Market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the increasing incidence of bone related injuries among the aging population due to osteoporosis or weak bone. Additionally, the growing demand for the best treatment with a low cost along with increasing awareness about new therapies such as joint manipulation and physical therapy which will significantly increase the demand for tendonitis treatment market across different parts of the globe. Additionally, the growing improvement of healthcare infrastructure for the treatment of bone disorder across the globe is further expected to increase the demand for tendonitis treatment, thereby fuelling market growth through 2027. Besides, growing awareness about maintaining a healthy lifestyle people are looking for sports activities which will further expected to support the tendonitis treatment market growth during the forecast period. Furthermore, increased number of sport-related injuries  due to either trauma or overuse of muscles or joints, improper rehabilitation, imbalanced training sessions is further expected to increase the demand for tendonitis treatment, thereby supporting market growth. According to the National Safety Council (NSC), in 2021, exercise equipment accounted for about 409,000 injuries, the most in any category of sports and recreation.

Increased Number of Sport-Related Injuries

The rapid increase in sport-related activities, causing sport-related injuries is expected to create lucrative growth during the forecast period. Sports injuries can cause soft tissue injuries which can be a major market driver across the globe. The number of people choosing sports as their career or hobby and getting work opportunities in the field of sports have increased.  Achilles tendinopathy affects 40% to 50% of competitive runners, according to a study by sports medicine experts from the University of Virginia and Duke University. Tendonitis is becoming more common day by day in the population and 5-10 cases per 100,000 population get affected which is expected to boost the market during the forecast period. Similarly, the number of patients are demanding physical therapy, and minimally invasive surgeries which will propel the market growth during the forecast period.

Stryker has launched the Citrelock Tendon Fixation Device system at the American Orthopaedic Foot and Ankle Society (AOFAS) annual meeting which was held from 22-25 September 2021 in Charlotte, North Carolina, US, and designed to enable fixation without causing damage to the tendon during placement.

Growing Aging Population

Different types of chronic disorders are affecting people across the globe. In Tendonitis, a thick fibrous cord that connects muscle and bone, becomes infected. The growing cases of Tendonitis, majorly among the aging population, is expected to enhance the demand for tendonitis treatment and boost the market growth during the forecast period. There are an estimated 32.0 million tendon injuries reported each year on average across the globe. So, most of the patients who are injured due to accidents demand physical therapy, over-the-counter pain relievers, and surgical procedures which will further propel the market growth during the forecast period. Eccentric strengthening is the main treatment for tendon disorders, so physical therapy is the first line of treatment for tendonitis which will boost the market growth during the forecast period.  These   are the major factor in the growth of the global Tendonitis Treatment Market in the forecast period. Every year in the U.S., about 30 million children and teens participate in some form of organized sports, and more than 3.5 million injuries each year due to sports injuries which will enhance the demand for tendonitis treatment. According to the National Safety Council (NSC), in 2021 exercise equipment accounted for about 409,000 injuries, the most in any category of sports and recreation.



Download Free Sample Report

 

Market Segmentation

The global tendonitis treatment market can be segmented by therapy, by condition and by region. Based on therapy, the market can be divided into Therapy and Surgery. Based on the condition, the market can be differentiated into Tennis Elbow, Golfer’s Elbow, Pitcher’s Elbow, Jumper’s Knee, and Others. Regionally, North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America. Among the different countries, the United States dominated the global tendonitis treatment market on account of the growing demand for advanced technology for the better treatment of tendonitis injuries in the country. As per studies, annually, around 775,000 adolescents receive therapies and treatments for sports-related injuries in the U.S.


Market Players

Merck and Co. Inc., Bayer AG, AstraZeneca Plc., Boehringer Ingelheim Pharmaceuticals, Inc., Abbott Laboratories, Inc., Pfizer, Inc., GlaxoSmithKline PLC, Almatica Pharma, Inc. are some of the leading players operating in the Global Tendonitis Treatment Market.

Recent Development

Clinical-stage cell therapy and regenerative medicine company InGeneron Inc. announced in July 2021 that it had published results of the world's first comprehensive immunohistochemical evaluation of adult tendon repair following local injection of fresh, uncultured and undamaged autologous cells from adipose tissue (UA-ADRCs).

Attribute

Details

Base Year

2022

Historic Data

2018 – 2021

Estimated Year

2023

Forecast Period

2024 – 2028

Quantitative Units

Revenue in USD Million, and CAGR for 2018-2022 and 2023-2028

Report Coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered

·         By Therapy

·         By Condition

·         By Region

Regional scope

North America; Europe; Asia Pacific; South America; Middle East & Africa

Country scope

United States; Canada; Mexico; France; Germany; United Kingdom; Italy; Spain; China; India; Japan; South Korea; Australia; Brazil; Argentina; Colombia; South Africa; Saudi Arabia; UAE

Key companies profiled

Merck and Co. Inc., Bayer AG, AstraZeneca Plc., Boehringer Ingelheim Pharmaceuticals, Inc., Abbott Laboratories, Inc., Pfizer, Inc., GlaxoSmithKline PLC, Almatica Pharma, Inc.

Customization scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Report Scope:

In this report, the global tendonitis treatment market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

  • Tendonitis Treatment Market, By Therapy:

o      Therapy

o      Surgery

·         Tendonitis Treatment Market, By Condition:

o      Tennis Elbow

o      Golfer’s Elbow

o      Pitcher’s Elbow

o      Jumper’s Knee

o      Others

·         Tendonitis Treatment Market, By Region:

o      North America

§  United States

§  Canada

§  Mexico

o      Europe

§  France

§  Germany

§  United Kingdom

§  Italy

§  Spain

o      Asia Pacific

§  China

§  India

§  Japan

§  South Korea

§  Australia

o      South America

§  Brazil

§  Argentina

§  Colombia

o      Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Tendonitis Treatment Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Global Tendonitis Treatment Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.     Markets Covered

1.2.2.     Years Considered for Study

1.2.3.     Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Sources

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, Trends

4.    Voice of Customer

4.1.  Prevalence of Tendonitis, By Age Group

4.2.  Prevalence of Tendonitis, By Gender

4.3.  Prevalence of Tendonitis, By Region

4.4.  Commonly Observed Tendonitis Conditions

5.    Global Tendonitis Treatment Market Outlook

5.1.  Market Size & Forecast

5.1.1.     By Value

5.2.  Market Share & Forecast

5.2.1.     By Therapy (Therapy v/s Surgery)

5.2.1.1.         By Therapy (Hot & Cold Therapy, Physical Therapy, Shockwave Therapy)

5.2.2.     By Condition (Tennis Elbow, Golfer’s Elbow, Pitcher’s Elbow, Jumper’s Knee, Others)

5.2.3.     By Region

5.2.4.     By Company (2022)

5.3.  Market Map

5.3.1.     By Therapy

5.3.2.     By Condition

5.3.3.     By Region

6.    North America Tendonitis Treatment Market Outlook

6.1.  Market Size & Forecast          

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Therapy (Therapy v/s Surgery)

6.2.1.1.         By Therapy (Hot & Cold Therapy, Physical Therapy, Shockwave Therapy)

6.2.2.     By Condition (Tennis Elbow, Golfer’s Elbow, Pitcher’s Elbow, Jumper’s Knee, Others)

6.2.3.     By Country

6.3.  North America: Country Analysis

6.3.1.     United States Tendonitis Treatment Market Outlook

6.3.1.1.         Market Size & Forecast

6.3.1.1.1.             By Value

6.3.1.2.         Market Share & Forecast

6.3.1.2.1.             By Therapy

6.3.1.2.2.             By Condition

6.3.2.     Canada Tendonitis Treatment Market Outlook

6.3.2.1.         Market Size & Forecast

6.3.2.1.1.             By Value

6.3.2.2.         Market Share & Forecast

6.3.2.2.1.             By Therapy

6.3.2.2.2.             By Condition

6.3.3.     Mexico Tendonitis Treatment Market Outlook

6.3.3.1.         Market Size & Forecast

6.3.3.1.1.             By Value

6.3.3.2.         Market Share & Forecast

6.3.3.2.1.             By Therapy

6.3.3.2.2.             By Condition

7.    Europe Tendonitis Treatment Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Therapy (Therapy v/s Surgery)

7.2.1.1.         By Therapy (Hot & Cold Therapy, Physical Therapy, Shockwave Therapy)

7.2.2.     By Condition (Tennis Elbow, Golfer’s Elbow, Pitcher’s Elbow, Jumper’s Knee, Others)

7.2.3.     By Country

7.3.  Europe: Country Analysis

7.3.1.     France Tendonitis Treatment Market Outlook

7.3.1.1.         Market Size & Forecast

7.3.1.1.1.             By Value

7.3.1.2.         Market Share & Forecast

7.3.1.2.1.             By Therapy

7.3.1.2.2.             By Condition

7.3.2.     Germany Tendonitis Treatment Market Outlook

7.3.2.1.         Market Size & Forecast

7.3.2.1.1.             By Value

7.3.2.2.         Market Share & Forecast

7.3.2.2.1.             By Therapy

7.3.2.2.2.             By Condition

7.3.3.     United Kingdom Tendonitis Treatment Market Outlook

7.3.3.1.         Market Size & Forecast

7.3.3.1.1.             By Value

7.3.3.2.         Market Share & Forecast

7.3.3.2.1.             By Therapy

7.3.3.2.2.             By Condition

7.3.4.     Italy Tendonitis Treatment Market Outlook

7.3.4.1.         Market Size & Forecast

7.3.4.1.1.             By Value

7.3.4.2.         Market Share & Forecast

7.3.4.2.1.             By Therapy

7.3.4.2.2.             By Condition

7.3.5.     Spain Tendonitis Treatment Market Outlook

7.3.5.1.         Market Size & Forecast

7.3.5.1.1.             By Value

7.3.5.2.         Market Share & Forecast

7.3.5.2.1.             By Therapy

7.3.5.2.2.             By Condition

8.    Asia-Pacific Tendonitis Treatment Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Therapy (Therapy v/s Surgery)

8.2.1.1.         By Therapy (Hot & Cold Therapy, Physical Therapy, Shockwave Therapy)

8.2.2.     By Condition (Tennis Elbow, Golfer’s Elbow, Pitcher’s Elbow, Jumper’s Knee, Others)

8.2.3.     By Country

8.3.  Asia-Pacific: Country Analysis

8.3.1.     China Tendonitis Treatment Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Therapy

8.3.1.2.2.             By Condition

8.3.2.     India Tendonitis Treatment Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Therapy

8.3.2.2.2.             By Condition

8.3.3.     Japan Tendonitis Treatment Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Therapy

8.3.3.2.2.             By Condition

8.3.4.     South Korea Tendonitis Treatment Market Outlook

8.3.4.1.         Market Size & Forecast

8.3.4.1.1.             By Value

8.3.4.2.         Market Share & Forecast

8.3.4.2.1.             By Therapy

8.3.4.2.2.             By Condition

8.3.5.     Australia Tendonitis Treatment Market Outlook

8.3.5.1.         Market Size & Forecast

8.3.5.1.1.             By Value

8.3.5.2.         Market Share & Forecast

8.3.5.2.1.             By Therapy

8.3.5.2.2.             By Condition

9.    South America Tendonitis Treatment Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Therapy (Therapy v/s Surgery)

9.2.1.1.         By Therapy (Hot & Cold Therapy, Physical Therapy, Shockwave Therapy)

9.2.2.     By Condition (Tennis Elbow, Golfer’s Elbow, Pitcher’s Elbow, Jumper’s Knee, Others)

9.2.3.     By Country

9.3.  South America: Country Analysis

9.3.1.     Brazil Tendonitis Treatment Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Therapy

9.3.1.2.2.             By Condition

9.3.2.     Argentina Tendonitis Treatment Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Therapy

9.3.2.2.2.             By Condition

9.3.3.     Colombia Tendonitis Treatment Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Therapy

9.3.3.2.2.             By Condition

10.  Middle East and Africa Tendonitis Treatment Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Therapy (Therapy v/s Surgery)

10.2.1.1.      By Therapy (Hot & Cold Therapy, Physical Therapy, Shockwave Therapy)

10.2.2.  By Condition (Tennis Elbow, Golfer’s Elbow, Pitcher’s Elbow, Jumper’s Knee, Others)

10.2.3.  By Country

10.3.              MEA: Country Analysis

10.3.1.  South Africa Tendonitis Treatment Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.           By Therapy

10.3.1.2.2.           By Condition

10.3.2.  Saudi Arabia Tendonitis Treatment Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.           By Therapy

10.3.2.2.2.           By Condition

10.3.3.  UAE Tendonitis Treatment Market Outlook

10.3.3.1.      Market Size & Forecast

10.3.3.1.1.           By Value

10.3.3.2.      Market Share & Forecast

10.3.3.2.1.           By Therapy

10.3.3.2.2.           By Condition

11.  Market Dynamics

11.1.              Drivers

11.2.              Challenges

12.  Market Trends & Developments

13.  Global Tendonitis Treatment Market: SWOT Analysis

14.  Porter’s Five Forces Analysis

14.1.              Competition in the Industry

14.2.              Potential of New Entrants

14.3.              Power of Suppliers

14.4.              Power of Customers

14.5.              Threat of Substitute Products

15.  Competitive Landscape

15.1.              Business Overview

15.2.              Product Offerings

15.3.              Recent Developments

15.4.              Financials (As Reported)

15.5.              Key Personnel

15.6.              SWOT Analysis

 

15.6.1    Merck and Co. Inc.

15.6.2    Bayer AG

15.6.3    AstraZeneca Plc.

15.6.4    Boehringer Ingelheim Pharmaceuticals, Inc.

15.6.5    Abbott Laboratories, Inc.

15.6.6    Pfizer, Inc.

15.6.7    GlaxoSmithKline PLC

15.6.8    Almatica Pharma, Inc.

Strategic Recommendations

Figures and Tables

Frequently asked questions

down-arrow

The growing prevalence of bone disorders, osteoarthritis, rheumatoid arthritis, and osteoporosis, making the geriatric population group susceptible to tendonitis, are some of the major factors driving the growth of the global tendonitis treatment market.

down-arrow

Merck and Co. Inc., Bayer AG, AstraZeneca Plc., Boehringer Ingelheim Pharmaceuticals, Inc., Abbott Laboratories, Inc., Pfizer, Inc., GlaxoSmithKline PLC, Almatica Pharma, Inc. are some of the leading players operating in the Global Tendonitis Treatment Market.

down-arrow

The tennis elbow is expected to dominate the global tendonitis treatment market during the forecast period.

down-arrow

North American region is expected to hold the largest share of the Global Tendonitis Treatment Market.

profile

Sakshi Bajaal

Business Consultant
Press Release

Tendonitis Treatment Market to be dominated by Automatic Device through 2028

Dec, 2022

The increasing number of sport-related injuries is expected to drive the Global Tendonitis Treatment Market in the forecast period, 2024-2028.